While this study confirms the clinical value of serum heparin-binding protein (HBP) and interleukin-6 (IL-6) in patients with severe pneumonia complicated by sepsis, several limitations should be acknowledged: First, the retrospective design inevitably leads to incomplete data collection and selection bias, which may restrict the generalizability of our findings. This evidence concerns the gene IL6 and Sepsis.